Our mission is to bring powerful self-diagnostic tools to help not just doctors, but anyone who prioritizes brain health. We’ve spent the last 3 decades building a team of experts to bring our first-of-its-kind eye-tracking technology to the world, so anyone can take their mental performance to the next level.
During COVID-19, we saw an opportunity to help bring brain health into everyday wellness. Not as a replacement for doctors and other health professionals, but as an accessible option to test and monitor brain health at home.
Eugene Melnyk is the Founder, Chairman, and Chief Executive Officer of Neurolign Technologies Incorporated. Eugene began his career by creating the medical publishing company Trimel Corporation. He then went on to become Founder and Chairman of Biovail Corporation, a specialty pharmaceutical company focused on research and development of advanced drug delivery technologies.
Under his leadership, Biovail became Canada’s largest publicly traded pharmaceutical company, generating more than $1 billion in annual revenue. Eugene assumed the role of sole Owner, Governor, and Chairman of the Ottawa Senators Hockey Club and Canadian Tire Centre on August 26, 2003. Under Melnyk’s ownership of the Senators, the team has made the playoffs on 9 occasions, including 2 trips to the Eastern Conference Final and 1 appearance in the Stanley Cup Final.
Eugene is involved in many philanthropic endeavors, mainly in the areas of childcare, medical research, and organ donation. He has close ties with military charities and is a proud supporter of the Armed Forces. In recognition, in September 2014, Canada’s then Minister of National Defence, the Honorable Rob Nicholson, appointed Melnyk as the Honorary Colonel of the 414 Electronic Warfare Squadron of the Canadian Armed Forces.
Colleen Sellers is the Chief Marketing Officer at Neurolign. Prior to her joining Neurolign, she served as the Vice President of Marketing at TytoCare, a transformative telemedicine device and platform. Before entering the health tech industry, Colleen led global and US brands at Johnson & Johnson, including Tylenol, Neutrogena, Zyrtec, and Visine. Colleen also worked at the BCG and the Federal Reserve Bank of New York. She has an MBA from the Kellogg School of Management and a BA from Smith College.
Prateek Dwivedi, also known as “Teek,” is the Chief Development Officer of Neurolign Technologies. He has more than 25 years of technology and healthcare leadership experience with a proven track record of developing and applying new technologies to solve important healthcare challenges. Teek has expertise in building next-generation health and research informatics platforms, as well as industry knowledge in telecommunications, sports, and entertainment. Teek earned his BASc and MASc in Systems Design Engineering from the University of Waterloo.
Alex Kiderman is the Vice President of Technology Development at Neurolign. Alex has more than 30 years of experience in engineering, medical diagnostics, and industrial manufacturing. He comes from Neuro Kinetics where he, as the Chief Technology Officer, led the numerous concussion and vestibular research initiatives resulting in 26 US-issued patents. Alex earned his engineering doctorate at the Academy of Science in Moscow, and has been published in more than 20 peer-reviewed publications.